1、投稿方式：在线投稿。

2、刊内网址（202502期）：

https://www.sciencedirect.com/journal/clinical-traditional-medicine-and-pharmacology

3、投稿系统：

https://www.editorialmanager.com/ctmph/default2.aspx

4、刊内邮箱：ccmp2020@163.com

5、刊内电话：0571-86613504

6、出刊日期：季刊，逢季末月出版。

7、刊内微信公众号：CTMP

2025年12月24日星期三

Guide for authors

【官网信息】

Introduction

Article types

Full-Length

Article: Present original research findings within CTMP's scope. Ensure

that the research is novel, adheres to ethical principles, and has

appropriate ethical approvals for human or animal studies. Follow

specific reporting standards, e.g., CONSORT.

Systematic

Review: Provide a comprehensive examination of relevant literature,

including both benefits and drawbacks of medicines or therapeutic

techniques. These reviews should not exceed 12,000 words and may contain

up to 12 figures and tables combined.

Meta-Analysis:

Publish meta-analyses shedding new light on crucial clinical research

topics. Include a structured abstract (max 300 words), with the main

text between 3,500 and 5,000 words, along with a table outlining study

characteristics and a study-selection flow chart. Adhere to PRISMA

guidelines.

Short

Communication: Share preliminary, relevant findings in a concise

format, avoiding the standard structure required for research papers.

Keep the length between 1,500 and 2,500 words, with no more than three

figures and tables combined. Present the "Results and Discussion"

sections individually or as a single section. Limit references to no

more than 20; note that we do not accept case reports.

Submission checklist

You

can use this list to carry out a final check of your submission before

you send it to the journal for review. Please check the relevant section

in this Guide for Authors for more details.

Ensure that the following items are present:

One author has been designated as the corresponding author with contact details:

E-mail address

Full postal address

All necessary files have been uploaded:

Manuscript

Include keywords

All figures (include relevant captions)

All tables (including titles, description, footnotes)

Ensure

all figure and table citations in the text match the files provided;

Indicate clearly if color should be used for any figures in print

Graphical Abstracts / Highlights files (where applicable)

Supplemental files (where applicable)

Further considerations:

Manuscript has been 'spell checked' and 'grammar checked'

All references mentioned in the Reference List are cited in the text, and vice versa

Permission has been obtained for use of copyrighted material from other sources (including the Internet)

A competing interests statement is provided, even if the authors have no competing interests to declare

Journal policies detailed in this guide have been reviewed

For further information, visit our Support Center.

Before you begin

Ethics in publishing

Please see our information on Ethics in publishing.

Declaration of interest

All

authors must disclose any financial and personal relationships with

other people or organizations that could inappropriately influence

(bias) their work. Examples of potential competing interests include

employment, consultancies, stock ownership, honoraria, paid expert

testimony, patent applications/registrations, and grants or other

funding. Authors must disclose any interests in two places: 1. A summary

declaration of interest statement in the title page file (if double

anonymized) or the manuscript file (if single anonymized). If there are

no interests to declare then please state this: 'Declarations of

interest: none'. 2. Detailed disclosures as part of a separate

Declaration of Interest form, which forms part of the journal's official

records. It is important for potential interests to be declared in both

places and that the information matches. More information.

Declaration of generative AI in scientific writing

Authors must declare the use of generative AI in the manuscript preparation process upon submission of the paper.

Elsevier

recognizes the potential of generative AI and AI-assisted technologies

(“AI Tools”), when used responsibly, to help researchers work

efficiently, gain critical insights fast and achieve better outcomes.

Increasingly, these tools, including AI agents and deep research tools,

are helping researchers to synthesize complex literature, provide an

overview of a field or research question, identify research gaps,

generate ideas, and provide tailored support for tasks such as content

organization and improving language and readability.

Authors

preparing a manuscript for an Elsevier journal can use AI Tools to

support them. However, these tools must never be used as a substitute

for human critical thinking, expertise and evaluation. AI technology

should always be applied with human oversight and control.

Ultimately, authors are responsible and accountable for the contents of their work. This includes accountability for:

Carefully

reviewing and verifying the accuracy, comprehensiveness, and

impartiality of all AI-generated output (including checking the sources,

as AI-generated references can be incorrect or fabricated).

Editing

and adapting all material thoroughly to ensure the manuscript

represents the author’s authentic and original contribution and reflects

their own analysis, interpretation, insights and ideas.

Ensuring

the use of any tools or sources, AI-based or otherwise, is made clear

and transparent to readers. If AI Tools have been used, we require a

disclosure statement upon submission; please see example below.

Ensuring

the manuscript is developed in a way that safeguards data privacy,

intellectual property and other rights, by checking the terms and

conditions of any AI tool that is used.

Finally,

authors must not list or cite AI Tools as an author or co-author on the

manuscript since authorship implies responsibilities and tasks that can

only be attributed to, and performed by, humans.

The

use of AI Tools in the manuscript preparation process must be declared

by adding a statement at the end of the manuscript when the paper is

first submitted. The statement will appear in the published work and

should be placed in a new section before the references list.

An example:

Title of new section: Declaration of generative AI and AI-assisted technologies in the manuscript preparation process.

Statement:

During the preparation of this work the author(s) used [NAME OF TOOL /

SERVICE] in order to [REASON]. After using this tool/service, the

author(s) reviewed and edited the content as needed and take(s) full

responsibility for the content of the published article.

The

declaration does not apply to the use of basic tools, such as tools

used to check grammar, spelling and references. If you have nothing to

disclose, you do not need to add a statement.

Please

read Elsevier’s author policy on the use of generative AI and

AI-assisted technologies, which can be found in our generative AI

policies for journals.

Please

note: to protect authors’ rights and the confidentiality of their

research, this journal does not currently allow the use of generative AI

or AI-assisted technologies such as ChatGPT or similar services by

reviewers or editors in the peer review and manuscript evaluation

process, as is stated in our generative AI policies for journals. We are

actively evaluating compliant AI Tools and may revise this policy in

the future.

Submission declaration and verification

Submission

of an article implies that the work described has not been published

previously (except in the form of an abstract, a published lecture or

academic thesis, see 'Multiple, redundant or concurrent publication' for

more information), that it is not under consideration for publication

elsewhere, that its publication is approved by all authors and tacitly

or explicitly by the responsible authorities where the work was carried

out, and that, if accepted, it will not be published elsewhere in the

same form, in English or in any other language, including electronically

without the written consent of the copyright-holder. To verify

compliance, your article may be checked by Crossref Similarity Check and

other originality or duplicate checking software.

Preprints

Please

note that preprints can be shared anywhere at any time, in line with

Elsevier's sharing policy. Sharing your preprints e.g. on a preprint

server will not count as prior publication (see 'Multiple, redundant or

concurrent publication' for more information).

Use of inclusive language

Inclusive

language acknowledges diversity, conveys respect to all people, is

sensitive to differences, and promotes equal opportunities. Content

should make no assumptions about the beliefs or commitments of any

reader; contain nothing which might imply that one individual is

superior to another on the grounds of age, gender, race, ethnicity,

culture, sexual orientation, disability or health condition; and use

inclusive language throughout. Authors should ensure that writing is

free from bias, stereotypes, slang, reference to dominant culture and/or

cultural assumptions. We advise to seek gender neutrality by using

plural nouns ("clinicians, patients/clients") as default/wherever

possible to avoid using "he, she," or "he/she." We recommend avoiding

the use of descriptors that refer to personal attributes such as age,

gender, race, ethnicity, culture, sexual orientation, disability or

health condition unless they are relevant and valid. When coding

terminology is used, we recommend to avoid offensive or exclusionary

terms such as "master", "slave", "blacklist" and "whitelist". We suggest

using alternatives that are more appropriate and (self-) explanatory

such as "primary", "secondary", "blocklist" and "allowlist". These

guidelines are meant as a point of reference to help identify

appropriate language but are by no means exhaustive or definitive.

Reporting sex- and gender-based analyses

Reporting guidance

For

research involving or pertaining to humans, animals or eukaryotic

cells, investigators should integrate sex and gender-based analyses

(SGBA) into their research design according to funder/sponsor

requirements and best practices within a field. Authors should address

the sex and/or gender dimensions of their research in their article. In

cases where they cannot, they should discuss this as a limitation to

their research's generalizability. Importantly, authors should

explicitly state what definitions of sex and/or gender they are applying

to enhance the precision, rigor and reproducibility of their research

and to avoid ambiguity or conflation of terms and the constructs to

which they refer (see Definitions section below). Authors can refer to

the Sex and Gender Equity in Research (SAGER) guidelines and the SAGER

guidelines checklist. These offer systematic approaches to the use and

editorial review of sex and gender information in study design, data

analysis, outcome reporting and research interpretation - however,

please note there is no single, universally agreed-upon set of

guidelines for defining sex and gender.

Definitions

Sex

generally refers to a set of biological attributes that are associated

with physical and physiological features (e.g., chromosomal genotype,

hormonal levels, internal and external anatomy). A binary sex

categorization (male/female) is usually designated at birth ("sex

assigned at birth"), most often based solely on the visible external

anatomy of a newborn. Gender generally refers to socially constructed

roles, behaviors, and identities of women, men and gender-diverse people

that occur in a historical and cultural context and may vary across

societies and over time. Gender influences how people view themselves

and each other, how they behave and interact and how power is

distributed in society. Sex and gender are often incorrectly portrayed

as binary (female/male or woman/man) and unchanging whereas these

constructs actually exist along a spectrum and include additional sex

categorizations and gender identities such as people who are

intersex/have differences of sex development (DSD) or identify as

non-binary. Moreover, the terms "sex" and "gender" can be

ambiguous--thus it is important for authors to define the manner in

which they are used. In addition to this definition guidance and the

SAGER guidelines, the resources on this page offer further insight

around sex and gender in research studies.

......

更多详见：

https://www.sciencedirect.com/journal/clinical-traditional-medicine-and-pharmacology/publish/guide-for-authors